Cargando…
Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
Glioblastoma multiforme (GBM) is the most common human primary brain malignancy and has a dismal prognosis. Aggressive treatments using maximal surgical resection, radiotherapy, and temozolomide result in median survival of only 14.6 months in patients with GBM. Numerous clinical approaches using sm...
Autores principales: | Lee, Jin-Ku, Joo, Kyeung Min, Lee, Jeongwu, Yoon, Yeup, Nam, Do-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211615/ https://www.ncbi.nlm.nih.gov/pubmed/25364264 http://dx.doi.org/10.2147/OTT.S36582 |
Ejemplares similares
-
In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015) -
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
por: Kang, Wonyoung, et al.
Publicado: (2015) -
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
por: Lee, Jaehyun, et al.
Publicado: (2018) -
Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds
por: Seo, Ji-Hye, et al.
Publicado: (2022) -
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
por: Lee, Se Jeong, et al.
Publicado: (2015)